Brief: Adaptimmune Therapeutics gets Nasdaq notice for non-compliance with minimum bid price
01/11/2024 22:10
Nov 1 (Reuters) - Adaptimmune Therapeutics PLC ADAP.O :
* ADAPTIMMUNE THERAPEUTICS PLC - RECEIVES NASDAQ NOTICE FOR
NON-COMPLIANCE WITH MINIMUM BID PRICE
Source text: ID:n0001558370-24-014148
Further company coverage: ADAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview